# bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test
Canonical URL: https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-announces-validation-study-with-brooke-army-medical-center-to-expand-sample-collection-options-for-the-cypathr-lung-noninvasive-early-detection-lung-cancer-test
Ticker: BIAF
Company: bioAffinity Technologies, Inc.
Source: bioAffinity Technologies, Inc.
Published: 2026-02-25 13:30 EST
Original Source URL: https://ir.bioaffinitytech.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-27 12:08 EST — [bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung](https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-publishes-new-clinical-framework-addressing-growing-mar-0496e8ef) — Source: bioAffinity Technologies, Inc.
- 2026-07-22 12:08 EST — [bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD](https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-and-pictor-inc-partner-to-develop-and-commercialize-bio-7ee819d4) — Source: bioAffinity Technologies, Inc.
- 2026-07-07 12:46 EST — [bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues](https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-quarterly-cypath-lung-sales-double-to-new-record-as-com-fee483fe) — Source: bioAffinity Technologies, Inc.
- 2026-06-22 12:00 EST — [bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells](https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-reports-positive-preclinical-findings-showing-proprieta-c62b401e) — Source: bioAffinity Technologies, Inc.
- 2026-06-18 17:16 EST — [bioAffinity Technologies Announces Closing of $3.2 Million Offering](https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-announces-closing-of-3-2-million-offering-d0a98ce9) — Source: bioAffinity Technologies, Inc.
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)